By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS




Collaborations

Acadia  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist 





Company News
PsychoGenics Achieves A Milestone In Drug Discovery Collaboration With Sunovion 6/13/2017 7:50:34 AM
FDA Rejects Sunovion's COPD NDA For SUN-101/eFlow 5/30/2017 6:39:27 AM
Sunovion Announces Positive Results From Pivotal Study Evaluating Novel Drug Candidate Dasotraline In Adults With Binge Eating Disorder At Annual American Psychiatric Association Meeting 5/24/2017 6:35:51 AM
Sunovion Presents Phase III Data Showing Safety, Efficacy And Improvement In Quality Of Life Outcomes In Patients With Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease Treated With SUN-101/Eflow (Glycopyrrolate) 5/23/2017 8:57:57 AM
Sunovion Announces Utibron Neohaler (Indacaterol/Glycopyrrolate) Inhalation Powder Data Showing Lung Function And Health-Related Quality Of Life Improvement In Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease 5/23/2017 8:46:30 AM
Sunovion Announces Positive Results From Study Evaluating Latuda (Lurasidone HCL) In Children And Adolescents With Bipolar Depression At Annual American Psychiatric Association Meeting 5/22/2017 11:11:55 AM
Sunovion Release: U.S. FDA Accepts For Review Supplemental New Drug Application For Aptiom (Eslicarbazepine Acetate) For The Treatment Of Partial-Onset Seizures In Children 4 To 17 Years Of Age 5/22/2017 7:26:22 AM
Sunovion Data Presentations At Annual American Psychiatric Association Meeting Showcase Growing Psychiatry Franchise 5/16/2017 6:50:41 AM
Sunovion To Present Clinical Efficacy, Safety And Health-Related Quality Of Life Outcomes Data From Its Respiratory Franchise At The American Thoracic Society 2017 International Conference 5/15/2017 8:38:32 AM
Sunovion Announces Positive Results From Pivotal Study Evaluating Novel Drug Candidate Dasotraline In Children With ADHD 4/21/2017 11:27:20 AM
12345678910...
//-->